ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

NCI Programs: Study Finds Bomb Tests Raised I-131 Exposure in 1950’s, 1960’s

August 22, 1997

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011